P3 Health Partners EBITDA Margin 2020-2025 | PIII
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for P3 Health Partners (PIII) over the last 10 years. The current EBITDA margin for P3 Health Partners as of September 30, 2025 is .
| P3 Health Partners EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $1.45B | $-0.16B | -11.00% |
| 2025-06-30 | $1.46B | $-0.23B | -15.87% |
| 2025-03-31 | $1.49B | $-0.23B | -15.42% |
| 2024-12-31 | $1.50B | $-0.23B | -15.60% |
| 2024-09-30 | $1.48B | $-0.16B | -10.84% |
| 2024-06-30 | $1.40B | $-0.09B | -6.21% |
| 2024-03-31 | $1.35B | $-0.08B | -5.62% |
| 2023-12-31 | $1.27B | $-0.08B | -6.40% |
| 2023-09-30 | $1.18B | $-0.09B | -7.56% |
| 2023-06-30 | $1.14B | $-0.12B | -10.11% |
| 2023-03-31 | $1.08B | $-0.16B | -14.39% |
| 2022-12-31 | $1.05B | $-0.16B | -15.06% |
| 2022-09-30 | $0.98B | $-0.22B | -22.54% |
| 2022-06-30 | $0.88B | $-0.21B | -23.64% |
| 2022-03-31 | $0.76B | $-0.20B | -25.66% |
| 2021-12-31 | $0.64B | $-0.18B | -27.79% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.021B | $1.500B |
| P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.977B | 41.61 |
| Tempus AI (TEM) | United States | $12.325B | 0.00 |
| Doximity (DOCS) | United States | $7.582B | 31.22 |
| Hims & Hers Health (HIMS) | United States | $7.130B | 58.00 |
| IRHYTHM HLDGS (IRTC) | United States | $5.259B | 0.00 |
| Hinge Health (HNGE) | United States | $3.411B | 0.00 |
| Heartflow (HTFL) | United States | $2.979B | 0.00 |
| Privia Health (PRVA) | United States | $2.811B | 175.77 |
| Inspire Medical Systems (INSP) | United States | $2.704B | 44.74 |
| 10x Genomics (TXG) | United States | $2.647B | 0.00 |
| Omnicell (OMCL) | United States | $2.276B | 46.53 |
| Azenta (AZTA) | United States | $1.817B | 74.53 |
| Clover Health Investments (CLOV) | United States | $1.452B | 0.00 |
| Enovis (ENOV) | United States | $1.388B | 7.29 |
| Schrodinger (SDGR) | United States | $1.350B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.250B | 0.00 |
| Phreesia (PHR) | United States | $0.971B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.865B | 0.00 |
| Talkspace (TALK) | United States | $0.628B | 126.33 |
| Standard BioTools (LAB) | United States | $0.611B | 0.00 |
| Claritev (CTEV) | United States | $0.504B | 0.00 |
| Evolent Health (EVH) | United States | $0.435B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.348B | 0.00 |
| Carlsmed (CARL) | United States | $0.339B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 15.14 |
| Zepp Health (ZEPP) | Netherlands | $0.299B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.293B | 0.00 |
| CapsoVision (CV) | United States | $0.276B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.258B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.196B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.174B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.169B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.122B | 6.67 |
| Outset Medical (OM) | United States | $0.099B | 0.00 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| HeartBeam (BEAT) | United States | $0.079B | 0.00 |
| American Well (AMWL) | United States | $0.077B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.072B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.050B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.042B | 0.00 |
| Precipio (PRPO) | United States | $0.042B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |